Mortality Rate and Predictive Factors for Death in Patients with ST-Elevation Acute Coronary Syndrome at Sisaket Hospital

Main Article Content

Apinya Boonkerng
Katthaleeya Srisuthom
Thanyaporn Sorod
Manasaphon Sommai

Abstract

Background: Mortality rate of ST-elevation acute coronary syndrome in Sisaket province is high and associated with patients with diabetes, hypertension, hyperlipidemia, smoking, and obesity. Identifying predictive factors were crucial for reducing mortality rate and establishing a cardiac network.
Objectives: The purpose is to identify the mortality rate and the predictive factors in patients with ST-elevation acute coronary syndrome in Sisaket Hospital.
Methods: A case-control study was conducted on patients with ST-elevation acute coronary syndrome in Sisaket hospital between 1st. October 2023 and 30th. September 2025. Data collection using medical records and the Thai ACS registry program. The endpoint was all-cause mortality and predictive factors of death.
Results: Of the 451 patients were included in the study. The mortality rate was 16.2% (73 patients). Majority of patients were elderly (age > 60 years old) about 73.1%. Predictive factors significantly associated with death were late presentation (aOR=4.12, 95%CI 1.12 – 15.15, p = 0.033), congestive heart failure on admission (aOR=3.39, 95%CI 1.01 – 11.34, p = 0.047), postprocedural cardiogenic shock (aOR=4.24, 95%CI 1.08 – 16.63, p =0.038) and renal failure acquired dialysis (aOR=10.46 ,95% CI 1.33-82.25, p = 0.026). However, patients treated with percutaneous coronary intervention (PCI), with a 93% reduction in the odds of death (aOR=0.069, 95% CI 0.01 – 0.28, p = 0.001) compared to the non-PCI group and statistically significant.
Conclusion: Mortality rate of patients with ST-elevation acute coronary syndrome in Sisaket Hospital is still high. Late presentation, congestive heart failure on admission, postprocedural cardiogenic shock, and renal failure requiring acquired dialysis are significant predictors of death.

Article Details

How to Cite
Boonkerng, A., Srisuthom, K., Sorod, T., & Sommai, M. (2026). Mortality Rate and Predictive Factors for Death in Patients with ST-Elevation Acute Coronary Syndrome at Sisaket Hospital. MEDICAL JOURNAL OF SISAKET SURIN BURIRAM HOSPITALS, 41(1), 247–255. retrieved from https://he02.tci-thaijo.org/index.php/MJSSBH/article/view/279936
Section
Original Articles

References

World Health Organization. Cardiovascular diseases (CVDs). [Internet]. [cited 2024 Aug 20]. Available from:URL: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

Rasool F, Khan MS, Ali A, Masood J. Prevalence of risk factors of ST elevated myocardial infarction. Value Health 2013;16:A665-A728.

Ralapanawa U, Kumarasiri PVR, Jayawickreme KP, Kumarihamy P, Wijeratne Y, Ekanayake M, et al. Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka. BMC Cardiovasc Disord 2019;19(1):229. doi: 10.1186/s12872-019-1217-x.

Sakboonyarat B, Rangsin R. Prevalence and associated factors of ischemic heart disease (IHD) among patients with diabetes mellitus: a nation-wide, cross-sectional survey. BMC Cardiovasc Disord 2018;18(1):151. doi: 10.1186/s12872-018-0887-0.

Laothavorn P, Hengrussamee K, Kanjanavanit R, Moleerergpoom W, Laorakpongse D, Pachirat O, et al. Thai Acute Decompensated Heart Failure Registry (Thai ADHERE). CVD Prev Control 2010;5(3)89-95. DOI: 10.1016/j.cvdpc.2010.06.001.

Callachan EL, Alsheikh-Ali AA, Wallis LA. Analysis of risk factors, presentation, and in-hospital events of very young patients presenting with ST-elevation myocardial infarction. J Saudi Heart Assoc 2017;29(4):270-5. doi: 10.1016/j.jsha.2017.01.004.

อนุวัตร์ รินทรวิฑูรย์, กมลนาถ มุขมณเฑียร, จอม สุวรรณ-โณ, เรวดี เพชรศิราสัณห์, เจนเนตร พลเพชร. ปัจจัยทำนายการเกิดอุบัติการณ์ชนิดรุนแรงในระยะเวลา 6 เดือนแรกหลังเกิดกล้ามเนื้อหัวใจขาดเลือดเฉียบพลันชนิด ST ยกสูงโดยใช้เครื่องมือ GRACE. วารสารพยาบาลโรคหัวใจและทรวง-อก 2563;31(2):160–73.

Shang C, Veliz DH, Arrocha MF, Martínez MIA, Assef HP. Cardiovascular risk factors in patients with ST-segment elevation myocardial infarction. CorSalud Revista Enfermedades Cardiovasc 2020;12(1):31–7.

Costa R, Trêpa M, Oliveira M, Frias A, Campinas A, Luz A, et al. Heart Failure Incidence Following ST-Elevation Myocardial Infarction. Am J Cardiol 2022;164:14-20. doi: 10.1016/j.amjcard.2021.10.035.

SABATÉ M, LÓPEZ-SOBRINO T, BRUGALETTA S. Cardiogenic Shock in STEMI : Current trends in management and the use of mechanical circulatory support devices. CIT 2020;14(3):34-7.

Shalaby G, Niazi AK, Khaled S. Cardiogenic Shock Among Patients with Acute ST-Segment Elevation Myocardial Infarction in a Middle Eastern Country: A Single-Center Experience.

J Saudi Heart Assoc 2023;34(4):232-40. doi: 10.37616/2212-5043.1323.

McNair PW, Bilchick KC, Keeley EC. Very late presentation in ST elevation myocardial infarction: Predictors and long-term mortality. Int J Cardiol Heart Vasc 2019;22:156-9. doi: 10.1016/j.ijcha.2019.02.002.

สำนักสื่อสารความเสี่ยงและพัฒนาพฤติกรรมสุขภาพ กองโรคไม่ติดต่อ กรมควบคุมโรค กระทรวงสาธารณสุข. กรมควบคุมโรค ร่วมรณรงค์วันหัวใจ โลก 2566 เผยปีที่แล้วคนไทยเสียชีวิตโรคหัวใจ และหลอดเลือดมากถึง 7 หมื่นราย ย้ำโรคนี้ สามารถป้องกันได้. [อินเตอร์เน็ต]. 2566. [สืบค้นเมื่อ 27 สิงหาคม 2567]. ค้นได้จาก:URL: https://ddc.moph.go.th/brc/news.php?news=37372&deptcode=brc

Schlesselman, J. J. (1982). Case-Control Studies: Design, Conduct, Analysis. New York, NY: Oxford University Press.

Newsome BB, Warnock DG, McClellan WM, Herzog CA, Kiefe CI, Eggers PW, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 2008;168(6):609-16. doi: 10.1001/archinte.168.6.609.